Starpharma’s Viraleze nasal spray effective against multiple Covid-19 variants
Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Jun 21
Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…
16 Jun 21
Sage and Biogen claimed that their investigational drug Zuranolone is a potential breakthrough in the management of depression
16 Jun 21
According to the new data, the AstraZeneca Covid-19 vaccine is 92% effective against the Delta variant, and 86%…
15 Jun 21
The Phase 3 PREVENT-19 study also met the key secondary endpoint of 100% efficacy against variants not considered…
14 Jun 21
Novavax vaccine against Beta (B.1.351) variant virus showed a high immunogenic response in mice and produced neutralising antibodies
28 May 21
Through a two-stage design, the phase 3 trial will evaluate vaccine formulations targeting original D.614 virus along with…
25 May 21
The coadministration trial is primarily aimed at determining the safety when both vaccines are co-administered, with follow up…
18 May 21
The vaccine showed immune responses consistent with those measured in people recovered from Covid-19, in all adult age…
10 May 21
The transaction will provide the combined entity with about $250m to fund its decentralised trial technology platform, expand…
21 Apr 21
Avigan is an anti-influenza drug, approved for domestic use in March 2014, for the treatment of new or…